Search results for " method"

showing 10 items of 10455 documents

Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbi…

2008

Summary Background The treatment of allergic asthma by specific immunotherapy (SIT) is hampered by potential side-effects. Objective The aim of this study was to study the effect of omalizumab, a monoclonal anti-IgE antibody, in combination with SIT in patients with seasonal allergic rhinoconjunctivitis (SAR) and co-morbid seasonal allergic asthma (SAA) incompletely controlled by conventional pharmacotherapy. Methods A randomized, double-blind, placebo-controlled, multi-centre trial was performed to assess the efficacy and safety of omalizumab (Xolair®) vs. placebo in combination with depigmented SIT (Depigoid®) during the grass pollen season. Omalizumab or placebo was started 2 weeks befor…

AdultMalemedicine.medical_specialtyAdolescentCombination therapyImmunologyOmalizumabOmalizumabAntibodies Monoclonal HumanizedPlacebolaw.inventionYoung AdultPharmacotherapyDouble-Blind MethodRandomized controlled triallawForced Expiratory VolumeInternal medicineAnti-Allergic AgentsmedicineClinical endpointHumansImmunology and AllergyChildConjunctivitis AllergicAsthmaPlant Extractsbusiness.industryAntibodies MonoclonalRhinitis Allergic SeasonalAntigens PlantMiddle Agedmedicine.diseaseCombined Modality TherapyAsthmaAntibodies Anti-IdiotypicRespiratory Function TestsTreatment OutcomeDesensitization ImmunologicAsthma Control QuestionnaireQuality of LifePhysical therapyPollenFemalebusinessmedicine.drugClinical & Experimental Allergy
researchProduct

Long-term effects of a multidisciplinary treatment of uncomplicated obesity on carotid intima-media thickness

2011

Obesity is associated with well-known cardiovascular risk factors and a lower life expectancy. This study investigated whether nonoperative nutritional treatment of obesity without comorbidities influenced the carotid intima-media thickness (c-IMT) in the long run. Fifty-four subjects of an original cohort of 251 subjects were re-evaluated 10 years after a medical nutritional treatment (MNT) with cognitive-behavioral approach for uncomplicated obesity. Forty subjects were classified as failure (10-year body weight change >0.5 kg) and 14 (body weight change ≤0.5 kg) as a success of the MNT. Ten years after MNT, c-IMT significantly increased (0.06 ± 0.02 mm; P = 0.004) in the failure group an…

AdultMalemedicine.medical_specialtyAdolescentDiet ReducingCarotid Artery CommonEndocrinology Diabetes and MetabolismMedicine (miscellaneous)Coronary Artery DiseaseWeight GainSeverity of Illness IndexBody Mass IndexCohort StudiesYoung AdultEndocrinologyBehavior TherapyRisk FactorsInternal medicineSeverity of illnessmedicineHumansSingle-Blind MethodObesityAgedNutrition and Dieteticsbusiness.industryAge FactorsMiddle AgedStepwise regressionmedicine.diseaseObesitySurgeryItalyIntima-media thicknessobesity treatment carotid intima-media thicknessCohortFemalemedicine.symptomTunica IntimaTunica MediabusinessWeight gainBody mass indexFollow-Up StudiesCohort study
researchProduct

Rosiglitazone Causes Endothelial Dysfunction in Humans

2011

We explored the impact of rosiglitazone on endothelial function in normal volunteers and its interaction with glyceryl trinitrate (GTN)-induced abnormalities in endothelial function. We hypothesized that rosiglitazone would have a neutral effect on endothelial function in normal volunteers and would favorably modify endothelial dysfunction induced by GTN.In this double-blind, randomized, placebo-controlled study, 44 participants were randomized to placebo, rosiglitazone (4 mg twice daily), transdermal GTN (0.6 mg/h), or both GTN and rosiglitazone. After 7 days of treatment, participants underwent measures of forearm blood flow during brachial artery infusion of acetylcholine (Ach). Serum gl…

AdultMalemedicine.medical_specialtyAdolescentEndotheliumVasodilator AgentsBlood PressureVasodilationAscorbic AcidPharmacologyPlaceboRosiglitazoneNitroglycerinYoung AdultDouble-Blind MethodHeart RateInternal medicinemedicine.arterymedicineHumansPharmacology (medical)Endothelial dysfunctionBrachial arteryPharmacologyDose-Response Relationship Drugbusiness.industrymedicine.diseaseAscorbic acidAcetylcholineVasodilationmedicine.anatomical_structureBlood pressureEndocrinologycardiovascular systemThiazolidinedionesEndothelium VascularCardiology and Cardiovascular MedicineRosiglitazonebusinesscirculatory and respiratory physiologymedicine.drugJournal of Cardiovascular Pharmacology and Therapeutics
researchProduct

Rationale for and design of the CREATIVE-AF trial: randomized, double-blind, placebo-controlled, crossover study of the effect of irbesartan on oxida…

2008

Background and objective: Atrial fibrillation (AF) is the most common cardiac arrhythmia. Recent studies suggest there is an angiotensin II-dependent increase in adhesion molecules and oxidative stress parameters during AF. These alterations appear to contribute to inflammatory and prothrombotic changes in the atrial endocardium (‘endocardial remodelling’), suggesting that patients with increased levels of these factors might be at risk of thromboembolic events. The purpose of the CREATIVE-AF (Impact of Irbesartan on Oxidative Stress and C-Reactive Protein Levels in Patients with Persistent Atrial Fibrillation) trial is to prove the principle concept that blockade of angiotensin II type 1 r…

AdultMalemedicine.medical_specialtyAdolescentEndpoint DeterminationTetrazolesmedicine.disease_causeYoung AdultIrbesartanVon Willebrand factorDouble-Blind MethodInternal medicineAtrial FibrillationmedicineHumansPharmacology (medical)Cell adhesionAgedCross-Over StudiesbiologyCell adhesion moleculebusiness.industryPatient SelectionBiphenyl CompoundsAtrial fibrillationGeneral MedicineIrbesartanMiddle Agedmedicine.diseaseAngiotensin IICrossover studyOxidative StressData Interpretation StatisticalSample SizeCardiologybiology.proteinFemalebusinessAngiotensin II Type 1 Receptor BlockersCell Adhesion MoleculesOxidative stressBiomarkersmedicine.drugClinical drug investigation
researchProduct

Comparison of 4% articaine with epinephrine (1:100,000) and without epinephrine in inferior alveolar block for tooth extraction: double-blind randomi…

2011

The purpose of this clinical prospective, randomized, double-blind study was to compare the anesthetic efficacy of 4% articaine with epinephrine (1:100,000) and without epinephrine in inferior alveolar nerve block anesthesia for extractions of mandibular teeth.Eighty-eight patients received intraoral inferior alveolar nerve blocks using 4% articaine with 1:100,000 epinephrine (n = 41; group 1) or without epinephrine (n = 47; group 2) for extractions of mandibular teeth. The primary objectives were differences in onset as well as in length of soft tissue anesthesia. The amount of anesthetic solution, need of a second injection, pain while injecting, pain during treatment, postoperative pain,…

AdultMalemedicine.medical_specialtyAdolescentEpinephrineAnesthesia DentalMandibular NerveOperative TimeMandibular nerveCarticaineAnesthetic AgentInferior alveolar nerveArticainePathology and Forensic Medicinelaw.inventionYoung AdultCarticaineDouble-Blind MethodRandomized controlled triallawHumansVasoconstrictor AgentsMedicineRadiology Nuclear Medicine and imagingDentistry (miscellaneous)Prospective StudiesAnesthetics LocalAgedAged 80 and overPain PostoperativeChi-Square Distributionbusiness.industryNerve BlockMiddle AgedSurgeryEpinephrineAnesthesiaTooth ExtractionAnestheticFemaleSurgeryOral Surgerybusinessmedicine.drugOral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
researchProduct

Short-term changes in median nerve neural tension after a suboccipital muscle inhibition technique in subjects with cervical whiplash: A randomised c…

2014

Abstract Objectives To assess the immediate effect of a suboccipital muscle inhibition (SMI) technique on: (a) neck pain, (b) elbow extension range of motion during the upper limb neurodynamic test of the median nerve (ULNT-1), and (c) grip strength in subjects with cervical whiplash; and determine the relationships between key variables. Design Randomised, single-blind, controlled clinical trial. Setting Faculty of Nursing, Physiotherapy and Podiatry, University of Seville, Spain. Participants Forty subjects {mean age 34 years [standard deviation (SD) 3.6]} with Grade I or II cervical whiplash and a positive response to the ULNT-1 were recruited and distributed into two study groups: inter…

AdultMalemedicine.medical_specialtyAdolescentFisioteràpiaVisual analogue scaleColl MalaltiesElbowPhysical Therapy Sports Therapy and Rehabilitationlaw.inventionGrip strengthRandomized controlled triallawElbow JointmedicineWhiplashHumansSingle-Blind MethodRange of Motion ArticularPhysical Therapy ModalitiesWhiplash InjuriesPain MeasurementNeck painHand Strengthbusiness.industryMiddle Agedmedicine.diseaseMedian NerveColumna vertebralmedicine.anatomical_structureRehabilitacióPhysical therapyUpper limbFemalemedicine.symptomRange of motionbusiness
researchProduct

B‐Mode ultrasonography of the paranasal sinuses compared with CT findings

1992

Ultrasound as a diagnostic aid in the evaluation of the sinuses has been a controversial issue. Sensitivities have been reported from 29% to 100% and specificities from 55% to 99%. These wide variations in results from previous studies may have resulted from technical differences. However, the "gold standard" most often used for comparison has been a Water's view radiograph, which has been shown to correlate poorly with intraoperative and CT scan findings. To our knowledge, no one in the English language literature has evaluated sonography of the sinuses with computed tomography as the gold standard. In addition, evaluation of the ethmoid sinus has been neglected by previous studies that ha…

AdultMalemedicine.medical_specialtyAdolescentMaxillary sinusRadiography03 medical and health sciences0302 clinical medicineEthmoid SinusPredictive Value of TestsEthmoid sinusParanasal SinusesParanasal Sinus Diseasesotorhinolaryngologic diseasesmedicineHumansSingle-Blind MethodProspective StudiesCt findingsChild030223 otorhinolaryngologyAgedUltrasonographyAged 80 and overFrontal sinusbusiness.industryUltrasoundGold standard (test)Maxillary SinusMiddle Agedmedicine.anatomical_structureParanasal sinusesOtorhinolaryngology030220 oncology & carcinogenesisFrontal SinusFemaleSurgeryRadiologyTomography X-Ray ComputedbusinessOtolaryngology–Head and Neck Surgery
researchProduct

Capecitabine plus oxaliplatin (CapOx) versus capecitabine plus gemcitabine (CapGem) versus gemcitabine plus oxaliplatin (mGemOx): final results of a …

2007

Abstract Background To compare the efficacy and safety of three different chemotherapy doublets in the treatment of advanced pancreatic cancer (PC). Patients and methods At total of 190 patients were randomly assigned to receive capecitabine 1000 mg/m2 twice daily on days 1–14 plus oxaliplatin 130 mg/m2 on day 1 (CapOx), capecitabine 825 mg/m2 twice daily on days 1–14 plus gemcitabine 1000 mg/m2 on days 1 and 8 (CapGem) or gemcitabine 1000 mg/m2 on days 1 and 8 plus oxaliplatin 130 mg/m2 on day 8 (mGemOx). Treatment cycles were repeated every three weeks. The primary end point was progression-free survival (PFS) rate at 3 months; secondary end points included objective response rate, carboh…

AdultMalemedicine.medical_specialtyAdolescentMaximum Tolerated DoseOrganoplatinum CompoundsPhases of clinical researchKaplan-Meier EstimateDeoxycytidineRisk AssessmentGastroenterologyDisease-Free SurvivalDrug Administration ScheduleCapecitabineInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansSingle-Blind MethodProgression-free survivalInfusions IntravenousCapecitabineAgedNeoplasm StagingProbabilityDose-Response Relationship Drugbusiness.industryCAPOX RegimenHematologyMiddle AgedImmunohistochemistrySurvival AnalysisGemcitabineGemcitabineOxaliplatinSurgeryOxaliplatinPancreatic NeoplasmsRegimenTreatment OutcomeOncologyTolerabilityFemaleFluorouracilbusinessFollow-Up Studiesmedicine.drugAnnals of Oncology
researchProduct

Efficacy of acupuncture for the prophylaxis of migraine: a multicentre randomised controlled clinical trial.

2006

Our aim was to assess the efficacy of a part-standardised verum acupuncture procedure, in accordance with the rules of traditional Chinese medicine, compared with that of part-standardised sham acupuncture and standard migraine prophylaxis with beta blockers, calcium-channel blockers, or antiepileptic drugs in the reduction of migraine days 26 weeks after the start of treatment.This study was a prospective, randomised, multicentre, double-blind, parallel-group, controlled, clinical trial, undertaken between April 2002 and July 2005. Patients who had two to six migraine attacks per month were randomly assigned verum acupuncture (n=313), sham acupuncture (n=339), or standard therapy (n=308). …

AdultMalemedicine.medical_specialtyAdolescentMigraine DisordersPopulationAcupuncture TherapyTraditional Chinese medicinelaw.inventionRandomized controlled trialDouble-Blind MethodlawInternal medicineAcupuncturemedicineConfidence IntervalsOdds RatioHumansProspective StudieseducationProspective cohort studyAgedRetrospective Studieseducation.field_of_studybusiness.industryRetrospective cohort studyMiddle Agedmedicine.diseaseClinical trialTreatment OutcomeMigrainePhysical therapyFemaleNeurology (clinical)businessThe Lancet. Neurology
researchProduct

Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depressi…

2003

OBJECTIVE Current clinical knowledge holds that antidepressants have a delayed onset of efficacy. However, the delayed onset hypothesis has been questioned recently by survival analytical approaches. We aimed to test whether early improvement under antidepressant treatment is a clinically useful predictor of later stable response and remission. METHOD We analyzed data from a randomized double-blind controlled trial with mirtazapine and paroxetine in patients with major depression (DSM-IV). Improvement was defined as a 17-item Hamilton Rating Scale for Depression (HAM-D-17) score reduction of > or = 20%. Stable response was defined as > or = 50% HAM-D-17 score reduction at week 4 and week 6,…

AdultMalemedicine.medical_specialtyAdolescentMirtazapineMirtazapineMianserinAntidepressive Agents TricyclicDrug Administration Schedulelaw.inventionRandomized controlled trialDouble-Blind MethodlawInternal medicinemedicineAmbulatory CareHumansPsychiatrySurvival analysisDepression (differential diagnoses)AgedPsychiatric Status Rating ScalesDepressive DisorderHamilton Rating Scale for DepressionMiddle AgedPrognosisParoxetineSurvival AnalysisClinical trialPsychiatry and Mental healthParoxetineTreatment OutcomeAntidepressantDrug Therapy CombinationFemalePsychologySelective Serotonin Reuptake Inhibitorsmedicine.drug
researchProduct